Literature DB >> 17360712

The effect of mutations in alpha-tropomyosin (E40K and E54K) that cause familial dilated cardiomyopathy on the regulatory mechanism of cardiac muscle thin filaments.

Mahmooda Mirza1, Paul Robinson, Elena Kremneva, O'neal Copeland, Olga Nikolaeva, Hugh Watkins, Dimitry Levitsky, Charles Redwood, Mohammed El-Mezgueldi, Steven Marston.   

Abstract

E40K and E54K mutations in alpha-tropomyosin cause inherited dilated cardiomyopathy. Previously we showed, using Ala-Ser alpha-tropomyosin (AS-alpha-Tm) expressed in Escherichia coli, that both mutations decrease Ca(2+) sensitivity. E40K also reduces V(max) of actin-Tm-activated S-1 ATPase by 18%. We investigated cooperative allosteric regulation by native Tm, AS-alpha-Tm, and the two dilated cardiomyopathy-causing mutants. AS-alpha-Tm has a lower cooperative unit size (6.5) than native alpha-tropomyosin (10.0). The E40K mutation reduced the size of the cooperative unit to 3.7, whereas E54K increased it to 8.0. For the equilibrium between On and Off states, the K(T) value was the same for all actin-Tm species; however, the K(T) value of actin-Tm-troponin at pCa 5 was 50% less for AS-alpha-Tm E40K than for AS-alpha-Tm and AS-alpha-Tm E54K. K(b), the "closed" to "blocked" equilibrium constant, was the same for all tropomyosin species. The E40K mutation reduced the affinity of tropomyosin for actin by 1.74-fold, but only when in the On state (in the presence of S-1). In contrast the E54K mutation reduced affinity by 3.5-fold only in the Off state. Differential scanning calorimetry measurements of AS-alpha-Tm showed that domain 3, assigned to the N terminus of tropomyosin, was strongly destabilized by both mutations. Additionally with AS-alpha-Tm E54K, we observed a unique new domain at 55 degrees C accounting for 25% of enthalpy indicating stabilization of part of the tropomyosin. The disease-causing mechanism of the E40K mutation may be accounted for by destabilization of the On state of the thin filaments; however, the E54K mutation has a more complex effect on tropomyosin structure and function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360712     DOI: 10.1074/jbc.M701071200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Why is it important to analyze the cardiac sarcomere subproteome?

Authors:  R John Solaro; Chad M Warren; Sarah B Scruggs
Journal:  Expert Rev Proteomics       Date:  2010-06       Impact factor: 3.940

2.  Use of 2-D DIGE analysis reveals altered phosphorylation in a tropomyosin mutant (Glu54Lys) linked to dilated cardiomyopathy.

Authors:  Chad M Warren; Grace M Arteaga; Sudarsan Rajan; Rafeeq P H Ahmed; David F Wieczorek; R John Solaro
Journal:  Proteomics       Date:  2008-01       Impact factor: 3.984

3.  HCM and DCM cardiomyopathy-linked α-tropomyosin mutations influence off-state stability and crossbridge interaction on thin filaments.

Authors:  Gerrie P Farman; Michael J Rynkiewicz; Marek Orzechowski; William Lehman; Jeffrey R Moore
Journal:  Arch Biochem Biophys       Date:  2018-04-05       Impact factor: 4.013

4.  How does genotype define phenotype? Microphysiology of a tropomyosin mutation in situ shows the limitations of reductionism.

Authors:  Steven Marston
Journal:  J Physiol       Date:  2008-06-15       Impact factor: 5.182

5.  Conserved noncanonical residue Gly-126 confers instability to the middle part of the tropomyosin molecule.

Authors:  Ilya A Nevzorov; Olga P Nikolaeva; Yaroslav A Kainov; Charles S Redwood; Dmitrii I Levitsky
Journal:  J Biol Chem       Date:  2011-03-14       Impact factor: 5.157

6.  Pathogenesis associated with a restrictive cardiomyopathy mutant in cardiac troponin T is due to reduced protein stability and greatly increased myofilament Ca2+ sensitivity.

Authors:  Michelle S Parvatiyar; Jose Renato Pinto
Journal:  Biochim Biophys Acta       Date:  2014-11-01

7.  The Effect of Tropomyosin Mutations on Actin-Tropomyosin Binding: In Search of Lost Time.

Authors:  William Lehman; Jeffrey R Moore; Stuart G Campbell; Michael J Rynkiewicz
Journal:  Biophys J       Date:  2019-05-13       Impact factor: 4.033

8.  Omecamtiv Mecarbil, a Cardiac Myosin Activator, Increases Ca2+ Sensitivity in Myofilaments With a Dilated Cardiomyopathy Mutant Tropomyosin E54K.

Authors:  Megan S Utter; David M Ryba; Betty H Li; Beata M Wolska; R John Solaro
Journal:  J Cardiovasc Pharmacol       Date:  2015-10       Impact factor: 3.105

Review 9.  Tropomyosin dynamics.

Authors:  Mohammed El-Mezgueldi
Journal:  J Muscle Res Cell Motil       Date:  2014-02-09       Impact factor: 2.698

10.  Phosphorylation of tropomyosin extends cooperative binding of myosin beyond a single regulatory unit.

Authors:  Vijay S Rao; Ellisha N Marongelli; William H Guilford
Journal:  Cell Motil Cytoskeleton       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.